1,431
Views
142
CrossRef citations to date
0
Altmetric
Research Article

Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig

, , , &
Pages 659-698 | Published online: 09 Oct 2008

REFERENCES

  • Adamson B., Schwarz D., Klugston P., Gilmont R., Perry L., Fisher J., Lindblad W., Rees R. Delayed repair: The role of glutathione in a rat incisional wound model. J. Surg. Res. 1996; 62: 159–164
  • Ademola J. I., Wester R. C., Maibach H. I. Metabolism of 3-indolylacetic acid during percutaneous absorption in human skin. J. Pharm. Sci. 1993; 82: 150–154
  • Agarwal R., Wang Z. Y., Bik D. P., Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab. Dispos. 1991; 19: 620–624
  • Ahmad N., Mukhtar H. Cytochrome P450: a target for drug development for skin diseases. J. Invest. Dermatol. 2004; 123: 417–425
  • Ahmad N., Agarwal R., Mukhtar H. Cytochrome P-450 and drug development for skin diseases. Skin Pharmacol. 1996; 9: 231–241
  • Aldini G., Granata P., Orioloi M., Santaniello E., Carini M. Detoxification of 4-hydroxynonenal (HNE) in keratinocytes: characterization of conjugated metabolites by liquid chromatography/electrospray ionization tandem mass spectrometry. J. Mass. Spectrom. 2003; 38: 1160–1168
  • Alonso L. E., Fuchs E. Stem cells of the skin epithelium. Proc. Natl. Acad. Sci. USA 2003; 100: 11830–11835
  • Altenburger R., Kissel T. The human keratinocyte cell line HaCaT: an in vitro cell culture model for keratinocyte testosterone metabolism. Pharm. Res. 1999; 16: 766–771
  • Alvares A. P., Kappas A., Levin W., Conney A. H. Inducibility of benzo(a)pyrene hydroxylase in human skin by polycyclic hydrocarbons. Clin. Pharmacol. Ther. 1973; 14: 30–40
  • Anderson R. J., Kudlacek P. E., Clemens D. L. Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem. Biol. Interact. 1998; 109: 53–67
  • Antille C., Tran C., Sorg O., Saurat J. H. Topical beta-carotene is converted to retinyl esters in human skin ex vivo and mouse skin in vivo. Exp. Dermatol. 2004; 13: 558–561
  • Arfsten D., Johnson E., Thitoff A., Jung A., Wilfong E., Lohrke S., Bausman T., Eggers J., Bobb A. Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology. Int. J. Toxicol. 2004; 23: 239–247
  • Asokan P., Das M., Bik D. P., Howard P. C., McCoy G. D., Rosenkranz H. S., Bickers D. R., Mukhtar H. Comparative effects of topically applied nitrated arenes and their nonnitrated parent arenes on cutaneous and hepatic drug and carcinogen metabolism in neonatal rats. Toxicol. Appl. Pharmacol. 1986; 86: 33–43
  • Audra L. Xenobiotic bioconversion in human epidermis models. Stinchcomb Pharmac. Res. 2003; 20: 1113–1118
  • Baron J., Kawabata T. T., Redick J. A., Knapp S. A., Wick D. G., Wallace R. B., Jakoby W. B., Guengerich F. P. Localization of carcinogen-metabolizing enzymes in human and animal tissues. Extrahepatic Drug Metabolism and Chemical Carcinogenesis, J. Rydström, J. Montelius, M. Bengtsson. Elsevier, Amsterdam 1983; 73–88
  • Baron J. M., Holler D., Schiffer R., Frankenberg S., Neis M., Merk H. F., Jugert F. K. Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 2001; 116: 541–548
  • Baschong W., Artmann C., Hueglin D., Roeding J. Direct evidence for bioconversion of vitamin E acetate into vitamin E: an ex vivo study in viable human skin. J. Cosmet. Sci. 2001; 52: 155–161
  • Bauer E., Guo Z., Ueng Y.-F., Bell L. C., Guengerich F. P. Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 1995; 8: 136–142
  • Beckley-Kartey S. A., Hotchkiss S. A., Capel M. Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse. Toxicol. Appl. Pharmacol. 1997; 145: 34–42
  • Bentley P., Schmassmann H., Sims P., Oesch F. Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase. A general assay and kinetic properties. Eur. J. Biochem. 1976; 69: 97–103
  • Bergstrom M. A., Ott H., Carlsson A., Neis M., Zwadlo-Klarwasser G., Jonsson C. A., Merk H. F., Karlberg A. T., Baron J. M. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. Nov 23, 2006, [Epub ahead of print]
  • Bernard F. X., Barrault C., Deguercy A. Expression of type 1 5α-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic): A new model for screening skin targeted androgen modulators. Int. J. Cosmet. Sci. 2000; 22: 397–407
  • Bi M., Singh J. Effect of buffer pH, buffer concentration and skin with or without enzyme inhibitors on the stability of [Arg(8)]-vasopressin. Int. J. Pharm. 2000; 197: 87–93
  • Bickers D. R., Mukhtar H. Skin as a portal entry for systemic effect of xenobiotic metabolism. Skin Pharmacology and Toxicology, Recent Advances, C. L. Galli, C. N. Hensby, M. Marinovich. Plenum Press, New York 1990; 85–97
  • Bickers D. R., Mukhtar H., Dutta-Choudhury T., Marcelo C. L., Voorhees J. J. Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. J. Invest. Dermatol. 1984; 83: 51–56
  • Bickers D. R., Mukhtar H., Meyer L. W., Speck W. T. Epidermal enzyme-mediated mutagenicity of the skin carcinogen, 2-aminoanthracene. Mutat. Res. 1985; 147: 37–43
  • Bikle D. D., Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr. Rev. 1993; 14: 3–19
  • Blacker K. L., Olsen E., Vessey D. A., Boyer T. D. Characterization of glutathione S-transferase in cultured human keratinocytes. J. Invest. Dermatol. 1991; 97: 442–446
  • Bock K. W., von Clausbruch U. C., Kaufmann R., Lilienblum W., Oesch F., Pfeil H., Platt K. L. Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. Biochem. Pharmacol. 1980; 29: 495–500
  • Boderke P., Schittkowski K., Wolf M., Merkle H. P. Modeling of diffusion and concurrent metabolism in cutaneous tissue. J. Theor. Biol. 2000; 204: 393–407
  • Boehnlein J., Sakr A., Lichtin J. L., Bronaugh R. L. Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption. Pharm. Res. 1994; 11: 1155–1159
  • Bonina F., Santagati N. A., Puglia C. Ketoprofen 1-alkylazacycloalkan-2-one esters as dermal prodrugs: in vivo and in vitro evaluations. Drug Dev. Ind. Pharm. 2003; 29: 181–190
  • Boukamp P., Petrussevska R. T., Breitkreutz D., Hornung J., Markham A., Fusenig N. E. Normal keratinization in a spontaneously immortalized aneuploid human. keratinocyte cell line. J. Cell Biol. 1988; 106: 761–771
  • Boyce S. T. Methods for the serum-free culture of keratinocytes and transplantation of collagen-GAG-based skin substitutes. Meth. Mol. Med. 1999; 18: 365–389
  • Briggs M. H., Briggs M. Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons. Br. J. Dermatol. 1973; 88: 75–81
  • Bronaugh R. L., Collier S. W., Macpherson S. E., Kraeling M. E. Influence of metabolism in skin on dosimetry after topical exposure. Environ. Health Perspect. 1994; 102: 71–74
  • Bronaugh R. L., Stewart R. F., Storm J. E. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 1989; 99: 534–543
  • Buckman S. Y., Gresham A., Hale P., Hruza G., Anast J., Masferrer J., Pentland A. P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998; 19: 723–729
  • Cereser C., Boget S., Parvaz P., Revol A. Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death. Toxicology 2001; 163: 153–162
  • Cheng J. B., Motola D. L., Mangelsdorf D. J., Russell D. W. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 2003; 278: 38084–38093
  • Cheung C., Davies N. G, Hoog J. O., Hotchkiss S. A., Smith Pease C. K. Species variations in cutaneous alcohol dehydrogenases and aldehyde dehydrogenases may impact on toxicological assessments of alcohols and aldehydes. Toxicology 2003b; 184: 97–112
  • Cheung C., Hotchkiss S. A., Pease C. K. Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. J. Dermatol. Sci. 2003a; 31: 9–19
  • Cheung C., Smith C. K., Hoog J. O., Hotchkiss S. A. M. Expression and localisation of human alcohol and aldehyde dehydrogenase enzymes in skin. Biochem. Biophys. Res. Commun. 1999; 261: 100–107
  • Chuang S. S., Helvig C., Taimi M., Ramshaw H. A., Collop A. H, Amad M., White J. A., Petkovich M., Jones G., Korczak B. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J. Biol. Chem. 2004; 279: 6305–6314
  • Del Tito B. J., Jr., Mukhtar H., Bickers D. R. Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid. Biochem. Biophys. Res. Commun. 1983; 114: 388–394
  • Ding S., Lake B. G., Friedberg T., Wolf C. R. Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem. J. 1995; 306: 161–166
  • Doebis C., Ritter T., Brandt C., Schonberger B., Volk H. D., Seifert M. Efficient in vitro transduction of epithelial cells and keratinocytes with improved adenoviral gene transfer for the application in skin tissue engineering. Transpl. Immunol. 2002; 9: 323–329
  • Dooley T. P. Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin. Exp. Dermatol. 1999; 8: 328–329
  • Dressler W. E., Appelqvist T. Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine. Fd. Chem. Toxicol. 2006; 44: 371–379
  • Du L., Hoffman S. M., Keeney D. S. Epidermal CYP2 family cytochromes P450. Toxicol. Appl. Pharmacol. 2004; 195: 278–287
  • Du L., Neis M. M., Ladd P. A., Keeney D. S. Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J. Pharmacol. Exp. Ther. 2006; 319: 1162–1171
  • Dudley B. F., Brimfield A. A., Winston G. W. Oxidation of thiodiglycol (2,2′-thiobis-ethanol) by alcohol dehydrogenase: comparison of human isoenzymes. J. Biochem. Mol. Toxicol. 2000; 14: 244–251
  • Duester G., Farres J., Felder M. R., Holmes R. S., Hoog J. O., Pares X., Plapp B. V., Yin S. J., Jornvall H. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem. Pharmacol. 1999; 58: 389–395
  • Eckert R. L., Crish J. F., Robinson N. A. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 1997; 77: 397–424
  • Einolf H. J., Story W. T., Marcus C. B., Larsen M. C., Jefcoate C. R., Greenlee W. F., Yagi H., Jerina D. M., Amin S., Park S. S., Gelboin H. V., Baird W. M. Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis. Chem. Res. Toxicol. 1997; 10: 609–617
  • Ekins S., Wrighton S. A. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 1999; 31: 719–754
  • Finnen M. J., Herdman M. L., Shuster S. Induction of drug metabolizing enzymes in the skin by topical steroids. J. Steroid Biochem. 1984; 20: 1169–1173
  • Finta C., Zaphiropoulos P. G. The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. Genomics 2000; 63: 433–438
  • Friedberg T., Grassow M. A., Bartlomowicz-Oesch B., Siegert P., Arand M., Adesnik M., Oesch F. Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver. Biochem. J. 1992; 287: 775–783
  • Friedberg T., Siegert P., Grassow M. A., Bartlomowicz B., Oesch F. Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues. Environ. Health Perspect. 1990; 88: 67–70
  • Garrigue J. L., Ballantyne M., Kumaravel T., Lloyd M., Nohynek G. J., Kirkland D., Toutain H. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N, N′-diacetyl metabolites. Mutat. Res. 2006; 608: 58–71
  • Gelardi A., Morini F., Dusatti F., Penco S., Ferro M. Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. Toxicol. In vitro 2001; 15: 701–711
  • Glatt H. R., Mertes I., Wölfel T., Oesch F. Epoxide hydrolases in laboratory animals and in man. Biochemical Basis of Chemical Carcinogenesis, H. Greim, R. Jung, M. Kramer, H. Marquardt, F. Oesch. Raven Press, New York 1984; 107–121
  • Goerz G., Barnstorf W., Winnekendonk G., Bolsen K., Fritsch C., Kalka K., Tsambaos D. Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes. Arch. Dermatol. Res. 1996; 289: 46–51
  • Goerz G., Bolsen K., Kalofoutis A., Tsambaos D. Influence of oral isotretinoin on hepatic and cutaneous P-450-dependent isozyme activities. Arch. Dermatol. Res. 1994; 286: 104–106
  • Goerz G., Tsambaos D., Schuppe H. C., Bolsen K., Georgiou S., Reinauer S., Zografakis C. Effects of human recombinant interferon-alpha 2b on P450-dependent isozymes in rat liver and skin. Skin Pharmacol. 1995; 8: 162–166
  • Gonzalez M. C., Marteau C., Franchi J., Migliore-Samour D. Cytochrome P450 4A11 in human keratinocytes: Effects of ultraviolet irradiation. Br. J. Dermatol. 2001; 145: 749–757
  • Guo J. F., Brown R., Rothwell C. E., Bernstein I. A. Levels of cytochrome P-450-mediated aryl hydrocarbon hydroxylase (AHH) are higher in differentiated than in germinative cutaneous keratinocytes. J. Invest. Dermatol. 1990; 94: 86–93
  • Guo Z., Gillam E. M., Ohmori S., Tukey R.H., Guengerich F.P. Expression of modified human cytochrome P450 IA1 in Escherichia coli: effects of 5′ substitution, stabilization, purification, spectral characterization and catalytic properties. Arch. Biochem. Biophys. 1994; 312: 436–446
  • Gupta V. K., Zatz J. L., Rerek M. Percutaneous absorption of sunscreens through micro-Yucatan pig skin in vitro. Pharm. Res. 1999; 16: 1602–1607
  • Gysler A., Lange K., Korting H. C., Schafer-Korting M. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharm. Res. 1997; 14: 793–797
  • Gysler A., Kleuser B., Sippl W., Lange K., Korting H. C., Holtje H. D., Korting H. C. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res. 1999; 16: 1386–1391
  • Haberland A., Santos Maia C., Jores K., Durrfeld M., Mehnert W., Schimke I., Christ B., Schafer-Korting M. Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. ALTEX 2003; 20: 3–9
  • Haberland A., Schreiber S., Maia C. S., Rubbelke M. K., Schaller M., Korting H. C., Kleuser B., Schimke I., Schafer-Korting M. The impact of skin viability on drug metabolism and permeation—BSA toxicity on primary keratinocytes. Toxicol In vitro 2006; 20: 347–354
  • Hansson J., Berhane K., Castro V. M., Jungnelius U., Mannervik B., Ringborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 1991; 51: 94–98
  • Hardingham T. E., Phelps C. F. The tissue content and turnover rates of intermediates in the biosynthesis of glycosaminoglacans in young rat skin. Biochem. J. 1968; 108: 9–16
  • Harris I. R., Siefken W., Beck-Oldach K., Brandt M., Wittern K. P., Pollet D. Comparison of activities dependent on glutathione S-transferase and cytochrome P-450 IA1 in cultured keratinocytes and reconstructed epidermal models. Skin Pharmacol. Appl. Skin Physiol. 2002a; 15: 59–67
  • Harris I. R., Siefken W., Beck-Oldach K., Wittern K. P., Pollet D. NAD(P)H:quinone reductase activity in human epidermal keratinocytes and reconstructed epidermal models. Skin Pharmacol. Appl. Skin Physiol. 2002b; 15: 68–73
  • Heise R., Mey J., Neis M. M., Marquardt Y., Joussen S., Ott H., Wiederholt T., Kurschat P., Megahed M., Bickers D. R., Merk H. F., Baron J. M. Skin retinoid concentrations are modulated by CYP26A1 expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. J. Invest. Dermatol. 2006; 126: 2473–2480
  • Hiratsuka A., Saito H., Hirose K., Watabe T. Marked expression of glutathione S-transferase A4-4 detoxifying 4-hydroxy-2(E)-nonenal in the skin of rats irradiated by ultraviolet B-band light (UVB). Biochem. Biophys. Res. Commun. 1999; 260: 740–746
  • Hirel B., Chesne C., Pailheret J. P., Guillouzo A. In vitro expression of drug metabolizing enzyme activities in human adult keratinocytes under various culture conditions and their response to inducers. In vitro Toxicol. 1995; 9: 49–56
  • Hirel B., Watier E., Chesne C., Patoux-Pibouin M., Guillouzo A. Culture and drug biotransformation capacity of adult human keratinocytes from post-mortem skin. Br. J. Dermatol. 1996; 134: 831–836
  • Honda A., Tint G. S., Shefer S., Batta A. K., Honda M., Salen G. Effect of YM 9429, a potent teratogen, on cholesterol biosynthesis in cultured cells and rat liver microsomes. Steroids. 1996; 61: 544–548
  • Honkakosi P., Negishi M. The structure, function and regulation of cytochrome P450 2A enzymes. Drug Metab. Rev. 1997; 272: 977–996
  • Inbaraj J., Chignell C. F. Cytotoxic action of jugolone and plumbagin: A mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 2004; 17: 55–62
  • Janmohamed A., Dolphin C. T., Phillips I. R., Shephard E. A. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem. Pharmacol. 2001; 62: 777–786
  • Jewell C., Heylings J., Clowes H. M., Williams F. M. Percutaneous absorption and metabolism of dinitrochlorobenzene in vitro. Arch. Toxicol. 2000; 74: 356–365
  • Jourdan E., Jeanne R. M., Steiman R., Guiraud P. Zink-metallothionein genoprotective effect is independent of the glutathione depletion in HaCaT keratinocytes after solar light irradiation. J. Cell. Biochem. 2004; 92: 631–640
  • Kang S., Li X. Y., Duell E. A., Voorhees J. J. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. J. Invest. Dermatol. 1997; 108: 513–518
  • Kao J., Patterson F. K., Hall J. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. Toxicol. Appl. Pharmacol. 1985; 81: 502–516
  • Katiyar S. K., Matsui M. S., Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol. 2000; 114: 328–333
  • Kawakubo Y., Merk H. F., Masaoudi T. A., Sieben S., Blomeke B. N-Acetylation of paraphenylenediamine in human skin and keratinocytes. J. Pharmacol. Exp. Ther. 2000; 292: 150–155
  • Keeney D. S., Skinner C., Wei S., Friedberg T., Waterman M. R. A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J. Biol. Chem. 1998; 273: 9279–9284
  • Khan W. A, Park S. S., Gelboin H. V., Bickers D. R., Mukhtar H. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat. J. Pharmacol. Exp. Ther. 1989; 249: 921–927
  • Khan I. U., Bickers D. R., Haqqi T. M., Mukhtar H. Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz(a)anthracene and beta-naphthoflavone. Drug Metab. Dispos. 1992; 20: 620–624
  • Kim P. M., Wells P. M. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Cancer Res. 1996; 56: 1526–1532
  • Kim P. M., Winn L. M., Parman T., Wells P. G. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin. J. Pharmacol. Exp. Ther. 1997; 280: 200–209
  • Kora B., Buzadzic B. Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast. J. Dermatol. Sci. 2001; 25: 45–52
  • Kurihara-Bergstrom T., Woodworth M., Feisullin S., Beall P. Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications. Lab Anim. Sci. 1986; 36: 396–399
  • Lee J. L., Mukhtar H., Bickers D. R., Kopelovich L., Athar M. Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol. Appl. Pharmacol. 2003; 192: 294–306
  • Ledirac N., Del escluse C., de Sousa G., Pralavorio M., Lesca P., Amichot M., Berge J. B., Rahmani R. Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptor. Toxicol. Appl. Pharmacol. 1997; 144: 177–182
  • Lehmann B., Tiebel O., Meurer M. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents – a preliminary study. Arch. Dermatol. Res. 1999; 291: 507–510
  • Lehmann B., Rudolph T., Pietzsch J., Meurer M. Conversion of vitamin D3 to 1,25-dihydroxyvitamin D3 in human skin equivalents. Exp. Dermatol. 2000; 9: 97–103
  • Leong J., Hughes-Fulford M., Rakhlin N., Habib A., Maclouf J., Goldyne M. E. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp. Cell Res. 1996; 224: 79–87
  • Levin W., Conney A. H., Alvares A. I., Merkatz I., Kappas A. Induction of benzo(a)pyrene hydroxylase in human skin. Science 1972; 176: 419–420
  • Levtchenko E., de Graaf-Hess A., Wilmer M., von den Heuvel L., Monnens L., Blom H. Altered status of glutathione and its metabolites in cystinotic cells. Nephrol. Dialysis Transplant. 2005; 20: 1828–1832
  • Li A., Pouliot N., Redvers R., Kaur P. Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. J. Clin. Invest. 2004; 113: 390–400
  • Lilienblum W., Irmscher G., Fusenig N. E., Bock K. W. Induction of UDP-glucuronyltransferase and arylhydrocarbon hydroxylase activity in mouse skin and in normal and transformed skin cells in culture. Biochem. Pharmacol. 1986; 35: 1517–1520
  • Lockley D. J., Howes D., Williams F. M. Cutaneous metabolism of glycol ethers. Arch. Toxicol. 2005; 79: 160–168
  • Lu A. Y., Wang R. W., Lin J. H. Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification. Drug Metab. Dispos. 2003; 31: 345–350
  • Mahmoud A., Haberland A., Durrfeld M., Heydeck D., Wagner S., Schafer-Korting M. Cutaneous estradiol permeation, penetration and metabolism in pig and man. Skin Pharmacol. Physiol. 2005; 18: 27–35
  • Mavon A., Raufast V., Redoules D. Skin absorption and metabolism of a new vitamin E prodrug, delta-tocopherol-glucoside: in vitro evaluation in human skin models. J. Contr. Rel. 2004; 100: 221–231
  • McCracken N. W., Blain P. G., Williams F. M. Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem. Pharmacol. 1993; 45: 31–36
  • Merk H. F., Baron J. M. Die Wirkung kleinmolekularer Substanzen auf die menschliche Haut. Molekulare Mechanismen und Konsequenzen. Hautarzt 2004; 55: 1125–1129
  • Merk H. F., Mukhtar H., Kaufmann I., Das M., Bickers D. R. Human hair follicle benzo(a)pyrene and benzo(a)pyrene 7,8-diol metabolism: Effect of exposure to a coal tar containing shampoo. J. Invest. Dermatol. 1987; 88: 71–76
  • Merk H. F., Khan W. A., Kuhn C., Bickers D. R., Mukhtar H. Effect of topical application of clotrimazole to rats on epidermal and hepatic monooxygenase activities and cytochrome P-450. Arch. Dermatol. Res. 1989; 281: 198–202
  • Merk H., Jugert F., Bonnekoh B., Mahrle G. Induction and inhibition of NAD(P)H: quinone reductase in murine and human skin. Skin Pharmacol. 1991; 4: 183–190
  • Moloney S. J., Fromson J. M., Bridges J. W. Cytochrome P-450 dependent deethylase activity in rat and hairless mouse skin microsomes. Biochem. Pharmacol. 1982a; 31: 4011–4018
  • Moloney S. J., Bridges J. W., Fromson J. M. UDP-glucuronosyltransferase activity in rat- and hairless mouse skin-microsomes. Xenobiotica 1982b; 12: 481–487
  • Moss T., Howes D., Williams F. M. Percutaneous penetration and dermal metabolism of triclosan (2, 4, 4′-trichloro-2′-hydroxydiphenyl ether). Fd. Chem. Toxicol. 2000; 38: 361–370
  • Mukhtar H., Bickers D. R. Drug metabolism in skin. Comparative activity of the mixed-function oxidases, epoxide hydratase, and glutathione S-transferase in liver and skin of the neonatal rat. Drug Metab. Dispos. 1981; 9: 311–314
  • Mukhtar H., Bickers D. R. Age related changes in benzo(a)pyrene metabolism and epoxide metabolizing enzyme activities in rat skin. Drug Metab. Dispos. 1983; 11: 562–567
  • Mukhtar H., Bresnick E. Glutathione-S-epoxide transferase in mouse skin and human foreskin. J. Invest. Dermatol. 1976; 66: 161–164
  • Mukhtar H., Del Tito B. J., Jr., Das M., Cherniack E. P., Cherniack A. D., Bickers D. R. Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon. Cancer Res. 1984; 44: 4233–4240
  • Mukhtar H., Athar M., Bickers D. R. Cytochrome P-450 dependent metabolism of testosterone in rat skin. Biochem. Biophys. Res. Commun. 1987; 145: 749–753
  • Mukhtar H., Agarwal R., Bickers D. R. Cutaneous metabolism of xenobiotics and steroid hormones. Pharmacology of the Skin, H. Mukhtar. CRC Press, Boca Raton, Florida 1991; 89–109
  • Nagata K., Gonzalez F. J., Yamazoe Y., Kato R. Purification and characterization of four catalytically active testosterone 6 beta-hydroxylase P-450s from rat liver microsomes: Comparison of a novel form with three structurally and functionally related forms. J. Biochem. (Tokyo). 1990; 107: 718–725
  • Ngawhirunpat T., Hatanaka T., Kawakami J., Adachi I. Age difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. Biol. Pharm. Bull. 2001; 24: 414–417
  • Nebert D. W., Dalton T. P., Okey A. B., Gonzalez F. J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004; 279: 23847–23850
  • Nohynek G. J., Duche D., Garrigues A., Meunier P. A., Toutain H., Leclaire J. Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol. Lett. 2005; 158: 196–212
  • Oesch F. Bedeutung verschiedener Enzyme in der Kontrolle mutagener und kanzerogener polyzyklischer Kohlenwasserstoffe. Der Hautarzt. 1977; 28: 563–573
  • Oesch F., Arand M. Xenobiotic metabolism. Toxicology, H. Marquardt, S. Schäfer, D. McLellan, C. Welsch. Academic Press, San Diego 1999; 83–110
  • Oesch-Bartlomowicz B., Oesch F. Mechanisms of toxification and detoxification which challenge drug candidates and drugs. Comprehensive Medicinal Chemistry, B. Testa, H. van de Waterbeemd. Elsevier, Oxford 2007; 193–214
  • Oesch F., Bentley P. Antibodies against homogeneous epoxide hydratase provide evidence for a single enzyme hydrating styrene oxide and benz(a)pyrene 4,5-oxide. Nature 1976; 259: 53–55
  • Oesch F., Glatt H., Schmassmann H. The apparent ubiquity of epoxide hydratase in rat organs. Biochem. Pharmacol. 1977; 26: 603–607
  • Oesch F., Schmassmann H., Bentley P. Specificity of human, rat and mouse skin epoxide hydratase towards K-region epoxides of polycyclic hydrocarbons. Biochem. Pharmacol. 1978; 27: 17–20
  • Oesch F., Tegtmeyer F., Kohl F. V., Rudiger H., Glatt H. R. Interindividual comparison of epoxide hydratase and glutathione S-transferase activities in cultured human fibroblasts. Carcinogenesis 1980; 1: 305–309
  • Oh S. Y., Fujii M., Takeda Y., Yoda K., Utoguchi N., Matsumoto M., Watanabe Y. The effect of ethanol on the simultaneous transport and metabolism of methyl p-hydroxybenzoate in excised skin of Yucatan micropig. Int. J. Pharm. 2002; 236: 35–42
  • Okun J. G., Sauer S., Bahr S., Lenhartz H., Mayatepek E. S-Acetylglutathione normalizes intracellular glutathione content in cultured fibroblasts from patients with glutathione synthetase deficiency. J. Inherit. Metab. Dis. 2004; 27: 783–786
  • Omdahl J. L., Bobrovnikova E. V., Annalora A., Chen P., Serda R. Expression, structure-function, and molecular modeling of vitamin D P450s. J. Cell Biochem. 2003; 88: 356–362
  • Peters W. H., Allebes W. A., Jansen P. L., Poels L. G., Cape P. J. Characterization and tissue specificity of a monoclonal antibody against human uridine 5′-diphosphate-glucuronosyltransferase. Gastroenterology 1987; 93: 162–169
  • Pham M. A., Magdalou J., Totis M., Fournel-Gigleux S., Siest G., Hammock B. D. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. Biochem. Pharmacol. 1989; 38: 2187–2194
  • Pham M. A., Magdalou J., Siest G., Lenoir M. C., Bernard B. A., Jamoulle J. C., Shroot B. Reconstituted epidermis: A novel model for the study of drug metabolism in human epidermis. J. Invest. Dermatol. 1990; 94: 749–752
  • Phillips T. L., Mitchell J. B., de Graff W., Russo A., Glatstein E. Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content. Int. J. Radiat. Oncol. Biol. Phys. 1986; 12: 1627–1635
  • Pillai O., Hamad M. O., Crooks P. A., Stinchcomb A. L. Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone. Pharm. Res. 2004; 21: 1146–1152
  • Rangarajan M., Zatz J. L. Effect of formulation on the delivery and metabolism of alpha-tocopheryl acetate. J. Cosmet. Sci. 2001; 52: 225–236
  • Ray S. S., Swanson H. I. Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin. Toxicol. Appl. Pharmacol. 2003; 192: 131–145
  • Raza H., Agarwal R., Bickers D. R., Mukhtar H. Purification and molecular characterization of beta-naphthoflavone-inducible cytochrome P-450 from rat epidermis. J. Invest. Dermatol. 1992; 98: 233–240
  • Raza H., Awasthi Y. C., Zaim M. T., Eckert R. L., Mukhtar H. Glutathione S-transferases in human and rodent skin: Multiple forms and species specific expression. J. Invest. Dermatol. 1991; 96: 463–467
  • Raza H., Mukhtar H. Differences in inducibility of cytochrome P-4501A1, monooxygenases and glutathione S-transferase in cutaneous and extracutaneous tissues after topical and parenteral administration of beta-naphthoflavone to rats. Int. J. Biochem. 1993; 25: 1511–1516
  • Rea M. A., Gregg J. P., Rice R. H. Expression profiling of TCDD-treated human epidermal cells in culture. Organohalogen Compd. 2002; 55: 469–472
  • Redoulès D., Tarroux R., Périé J. J. Composition pharmaceutique ou cosmétique contenant un précurseur d'actif hydrolysable par la β-glucocerebrosidase. Pierre Fabre DermoCosmétique Patent PCT/FR99/00521, 1999
  • Rees R. S., Kingman G. J., Cashmer B., Gilmont R. R., Reeves C., Welsh M. J., Smith D. J., Jr. dT diaphorase: increased enzyme activity and mRNA expression in oxidant stress of skin. J. Surg. Res. 1994; 56: 326–330
  • Rees R. S., Smith D. J., Jr., Adamson B., Im M., Hinshaw D. Oxidant stress: The role of the glutathione redox cycle in skin preconditioning. J. Surg. Res. 1995; 58: 395–400
  • Reilly T. P., Lash L. H., Doll M. A., Hein D. W., Woster P. M., Svensson C. K. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J. Invest. Dermatol. 2000; 114: 1164–1173
  • Richter-Hintz D., Their R., Steinwachs S., Kronenberg S., Fritsche E., Sachs B., Wulferink M., Tonn T., Esser C. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J. Invest. Dermatol. 2003; 120: 765–770
  • Rittirod T., Hatanaka T., Uraki A., Hino K., Katayama K., Koizumi T. Species difference in simultaneous transport and metabolism of ethyl nicotinate in skin. Int. J. Pharm. 1999; 178: 161–169
  • Rivier M., Castiel I., Safonova I., Ailhaud G., Michel S. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J. Invest. Dermatol. 2000; 114: 681–687
  • Rogoff D., Gomez-Sanchez C. E., Foecking M. F., Wortsman J., Slominski A. Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J. Steroid Biochem. Mol. Biol. 2001; 78: 77–81
  • Roguet R., Cotovio J., Leclaire J. Reconstructed skin for in vitro cutaneous pharmacotoxicology: Example of metabolic studies. Toxicol. In vitro 1997; 10: 3–9
  • Romeu M., Mulero M., Giralt M., Folch J., Nogues M. R., Torres A., Fortuno A., Sureda F. X., Cabre M., Paternain J. L., Mallo J. Parameters related to oxygen free radicals in erythrocytes, plasma and epidermis of the hairless rat. Life Sci. 2002; 71: 1739–1749
  • Roychowdhury S., Svensson C. K. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J. 2005; 7: 834–846
  • Saarikoski S. T., Wikman H. A., Smith G., Wolff C. H., Husgafvel-Pursiainen K. Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridisation and immunohistochemistry. J. Histochem. Cytochem. 2005a; 53: 549–556
  • Saarikoski S. T., Rivera S. P., Hankinson O., Husgafvel-Pursiainen K. CYP2S1: A short review. Toxicol. Appl. Pharmacol. 2005b; 207: 62–69
  • Särnstrand B., Eriksson G., Malmström A. Glucocorticoids change the nucleotide and sugar nucleotide pool sizes in cultured human skin fibroblasts. Arch. Biochem. Biophys. 1987; 252: 315–321
  • Saeki M., Saito Y., Nagano M., Teshimia R., Ozawa S., Sawada J. mRNA expression of multiple cytochromes P450 isozymes in four types of cultured skin cells. Int. Arch. Allergy Immunol. 2002; 127: 333–336
  • Sauer B., Vogler R., von Wenckstern H., Fujii M., Anzano M. B., Glick A. B., Schäfer-Korting M., Roberts A. B., Kleuser B. Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J. Biol. Chem. 2004; 279: 38471–38479
  • Schmook F. P., Meingassner J. G., Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm. 2001; 215: 51–56
  • Schober W., Luch A., Soballa V. J., Raab G., Stegeman J. J., Doehmer J., Jacob J., Seidel A. On the species-specific biotransformation of dibenzo[a, l]pyrene. Chem. Biol. Interact. 2006; 161: 37–48
  • Semak I., Korik E., Naumova M., Wortsman J., Slominski A. Serotonin metabolism in rat skin: Characterization by liquid chromatography-massspectrometry. Arch. Biochem. Biophys. 2004; 421: 61–66
  • Shuster S., Rawlins M. D., Chapman P. H., Rogers S. Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis. Br. J. Dermatol. 1980; 103: 23–26
  • Sieben S., Baron J. M., Blomeke B., Merk H. F. Multiple cytochrome P450-isoenzymes mRNA are expressed in dendritic cells. Int. Arch. Allergy Immunol. 1999; 118: 358–361
  • Slivka S. R. Testosterone metabolism in an in vitro skin model. Cell Biol.Toxicol. 1992; 8: 267–276
  • Slominski A., Wortsman J., Foecking M. F., Shackleton C., Gomez-Sanchez C., Szczesniewski A. Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. J. Invest. Dermatol. 2002; 118: 310–315
  • Slominski A., Zjawiony J., Wortsman J., Semak I., Stewart J., Pisarchik A., Sweatman T., Marcos J., Dunbar C. C., Tuckey R. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur. J. Biochem. 2004; 271: 4178–4188
  • Smith C. K., Hotchkiss S. A. M. Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms. Taylor & Francis, London 2001
  • Smith C. K., Moore C. A., Elahi E. N., Smart A. T., Hotchkiss S. A. Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. Toxicol. Appl. Pharmacol. 2000; 168: 189–199
  • Smith G., Wolf C. R., Deeni Y. Y., Dawe R. S., Evans A. T., Comrie M. M., Ferguson J., Ibbotson S. H. Cutaneous expression of cytochrome P450 CYP2S1: Individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 2003; 361: 1336–1343
  • Stinchcomb A. L. Xenobiotic bioconversion in human epidermis models. Pharm. Res. 2003; 20: 1113–1118
  • Stinchcomb A. L., Swaan P. W., Ekabo O., Harris K. K., Browe J., Hammell D. C., Cooperman T. A., Pearsall M. Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. J. Pharm. Sci. 2002; 91: 2571–2578
  • Storm J. E., Collier S. W., Stewart R. F., Bronaugh R. L. Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity. Fundam. Appl. Toxicol. 1990; 15: 132–141
  • Strobl G. R., von Kruedener S., Stiickigt J., Guengerich F. P., Wolff T. Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J. Med. Chem. 1988; 36: 1136–1145
  • Strobl G., Heinrich B., Wolff T., Guengerich F. P. (1993) Inhibition of bufuralol 1′-hydroxylation in rat and human liver: in vitro studies and inhibitor modeling. Abstracts, Sixth Symposium on Biochemistry and Biophysics of Cytochrome P-450, Vienna, July, 1993
  • Strohm B. H., Kulkarni A. P. Peroxidase, an alternate pathway to cytochrome P-450 for xenobiotic metabolism in skin: partial purification and properties of the enzyme from neonatal rat skin. J. Biochem. Toxicol. 1986; 1: 83–97
  • Sugibayashi K., Hayashi T., Morimoto Y. Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: The effect of enzyme distribution in skin. J. Control Rel. 1999; 62: 201–208
  • Sugibayashi K., Hayashi T., Matsumoto K., Hasegawa T. Utility of a three-dimensional cultured human skin model as a tool to evaluate the simultaneous diffusion and metabolism of ethyl nicotinate in skin. Drug Metab. Pharmacokin. 2004; 19: 352–362
  • Suppasansatorn P., Wang G., Conway B. R., Wang W., Wang Y. Skin delivery potency and antitumor activities of temozolomide ester prodrugs. Cancer Lett. 2006; 244: 42–52
  • Sutter T. R., Tang Y. M., Hayes C. L., Wo Y. Y., Jabs E. W., Li X., Yin H., Cody C. W., Greenlee W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 1994; 269: 13092–13099
  • Swanson H. I. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem. Biol. Interact. 2004; 149: 69–79
  • Taimi M., Helvig C., Wisniewski J., Ramshaw H., White J., Amad M., Korczak B., Petkovich M. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomer of retinoic acid. J. Biol. Chem. 2004; 279: 77–85
  • Takahara H., Zaidi S. I., Mukhtar H., Handa M., Epstein W. L., Fukuyama K. Purification and characterization of NADPH-cytochrome P-450 reductase from rat epidermis. J. Cell Biochem. 1993; 53: 206–212
  • Tashiro K., Abe T., Oue N., Yasui W., Ryoji M. Characterization of vitamin D-mediated induction of the CYP 24 transcription. Mol. Cell Endocrinol. 2004; 226: 27–32
  • Thiboutot D., Jabara S., McAllister J. M., Sivarajah A., Gilliland K., Cong Z., Clawson G. Human skin is a steroidogenic tissue: Steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J. Invest. Dermatol. 2003; 120: 905–914
  • Törmä H., Vahlquist A. Vitamin A esterification in human epidermis: a relation to keratinocyte differentiation. J. Invest. Dermatol. 1990; 94: 132–138
  • Tse F. L., Laplanche R. Absorption, metabolism, and disposition of [14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in minipigs following oral, intravenous, and dermal administration. Pharm. Res. 1998; 15: 1614–1620
  • Tunali T., Sener G., Yarat A., Emekli N. Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. Life Sci. 2004; 76: 1259–1265
  • Ueda O., Kitamura S., Ohashi K., Sugihara K., Ohta S. Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin. Drug Metab. Dispos. 2003; 31: 367–372
  • Vance W. A., Wang Y. Y., Okamoto H. S. Disubstituted amino-, nitroso- and nitrofluorenes: A physicochemical basis for structure-activity relationships in Salmonella typhimurium. Environ. Mutagen. 1987; 9: 123–141
  • Vanden Bossche H., Willemsens G., Janssen P. A. Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. Skin Pharmacol. 1988; 1: 176–185
  • Vecchini F., Mace K., Magdalou J., Mahe Y., Bernard B. A., Shroot B. Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes. Br. J. Dermatol. 1995; 132: 14–21
  • Vickers A. E. M., Biggi W. A., Dannecker R., Fischer V. Uptake and metabolism of cyclosporin A and SDZ IMM 125 in the human in vitro Skin2 dermal and barrier function models. Life Sci. 1995; 57: 215–224
  • Vienneau D. S., DeBoni U., Wells P. G. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: Initiation of micronuclei by benzo[a]pyrene and benzo[e]pyrene in UDP-glucuronosyltransferase–deficient cultured rat skin fibroblasts. Cancer Res. 1995; 55: 1045–1051
  • Villard P. H., Sampol E., Elkaim J. L., Puyoou F., Casanova D., Seree E., Durand A., Lacarelle B. Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure. Toxicol. Appl. Pharmacol. 2002; 178: 37–43
  • Vondracek M., Xi Z., Larsson P., Baker V., Mace K., Pfeifer A., Tjalve H., Donato M. T., Gomez-Lechon M. J., Grafstrom R. C. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 2001; 22: 481–488
  • Vyas P. M., Roychowdhury S., Koukouritak S. B, Hines R. N., Krueger S. K., Williams D. E., Nauseef W. M., Svensson C. K. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases. J. Pharmacol. Exp. Ther. 2006; 319: 497–505
  • Watt F. M., Jordan P. W., O'Neill C.H. Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc. Natl. Acad. Sci. USA 1988; 85: 5576–5580
  • Wattenberg L. W., Leong J. L. Histochemical studies of polycyclic hydrocarbon metabolizing systems. J. Histochem. Soc. 1962; 10: 659
  • Westerlund M., Galter D., Carmine A., Olson L. Tissue- and species-specific expression patterns of class I, III, and IV Adh and Aldh 1 mRNAs in rodent embryos. Cell Tissue Res. 2005; 322: 227–236
  • Weston A., Grover P. L., Sims P. Metabolism and activation of benzo[a]pyrene by mouse and rat skin in short-term organ culture and in vivo. Chem. Biol. Interact. 1982; 42: 233–250
  • White J. A., Beckett-Jones B., Guo Y. D., Dilworth F. J., Bonasoro J., Jones G., Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J. Biol. Chem. 1997; 272: 18538–18541
  • Whitlock J. P. The regulation of cytochrome P450 gene expression. Annu. Rev. Pharmacol. Toxicol. 1987; 26: 333–369
  • Wong K. O., Tan A. Y., Lim B. G., Wong K. P. Sulphate conjugation of minoxidil in rat skin. Biochem. Pharmacol. 1993; 45: 1180–1182
  • Yahata Y., Shirakata Y., Tokumaru S., Yang L., Dai X., Tohyama M., Tsuda T., Sayama K., Iwai M., Horiuchi M., Hashimoto K. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J. Biol. Chem. 2006; 281: 13209–13216
  • Yarat A., Tunali T., Yanardag R., Gürsoy F., Sacan Ö., Emekli N., Üstüner A., Ergenekon G. The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes. Free Radic. Biol. Med. 2001; 31: 1038–1042
  • Yengi L.G., Xiang Q., Pan J., Scatina J., Kao J., Ball S. E., Fruncillo R., Ferron G., Wolf C. R. Quantitation of cytochrome P450 mRNA levels in human skin. Anal. Biochem. 2003; 316: 103–110
  • Yourick J. J., Bronaugh R. L. Percutaneous absorption and metabolism of Coumarin in human and rat skin. J. Appl. Toxicol. 1997; 17: 153–158
  • Zaphiropoulos P. G. RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver. Nucl. Acids Res. 1999; 27: 2585–2590
  • Zhu Z., Hotchkiss S. A., Boobis A. R., Edwards R. J. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. Biochem. Biophys. Res. Commun. 2002; 297: 65–70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.